EUCRW

Eucrates Biomedical Acquisition Corp. Warrant
EUCRW

Delisted

EUCRW was delisted on the 26th of April, 2023.

0 hedge funds and large institutions have $0 invested in Eucrates Biomedical Acquisition Corp. Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 22 closing their positions.

Holders
Holders Change
-22
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
DM
1
Deerfield Management
New York
-333,333 Closed
CAC
2
Cowen and Company
New York
-202,371 Closed
6CM
3
683 Capital Management
New York
-196,348 Closed
ACM
4
Altium Capital Management
New York
-133,333 Closed
AI
5
Arena Investors
New York
-94,516 Closed
EC
6
EcoR1 Capital
California
-66,666 Closed
KCM
7
Kingdon Capital Management
New York
-66,665 Closed
RCM
8
Rivernorth Capital Management
Florida
-58,548 Closed
AA
9
AQR Arbitrage
Connecticut
-45,832 Closed
KPF
10
K2 Principal Fund
Ontario, Canada
-34,509 Closed
RCM
11
Radcliffe Capital Management
Pennsylvania
-33,333 Closed
CIM
12
Cowen Investment Management
New York
-33,333 Closed
CH
13
CVI Holdings
Delaware
-30,854 Closed
Jane Street
14
Jane Street
New York
-26,838 Closed
HIM
15
HGC Investment Management
Ontario, Canada
-26,383 Closed
SIA
16
Schechter Investment Advisors
Michigan
-26,087 Closed
SC
17
Sculptor Capital
New York
-25,881 Closed
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
-22,697 Closed
Citadel Advisors
19
Citadel Advisors
Florida
-18,173 Closed
CS
20
Clear Street
New York
-2,637 Closed
Morgan Stanley
21
Morgan Stanley
New York
-1,300 Closed
Bank of America
22
Bank of America
North Carolina
-215 Closed
CFGS
23
Concourse Financial Group Securities
Alabama